Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 460 | 250 | 1,480 | 460 | 450 |
| Depreciation Amortization | 2,470 | 1,290 | 4,630 | 3,240 | 2,160 |
| Other Working Capital | -410 | -160 | -6,100 | -4,240 | -3,340 |
| Other Operating Activity | -1,270 | 110 | -210 | -90 | 50 |
| Operating Cash Flow | $1,250 | $1,490 | $-200 | $-630 | $-680 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,290 | -960 | -4,510 | -1,810 | -1,070 |
| Other Investing Activity | 460 | 10 | 4,940 | 1,690 | 1,550 |
| Investing Cash Flow | $-830 | $-950 | $430 | $-120 | $480 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 60 | 80 | 130 | 190 | 130 |
| Financing Cash Flow | $60 | $80 | $130 | $190 | $130 |
| Beginning Cash Position | 4,580 | 4,580 | 4,210 | 4,210 | 4,210 |
| End Cash Position | 5,060 | 5,200 | 4,580 | 3,650 | 4,150 |
| Net Cash Flow | $470 | $620 | $360 | $-560 | $-60 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,250 | 1,490 | -200 | -630 | -680 |
| Free Cash Flow | 1,250 | 1,490 | -200 | -630 | -680 |